- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07603635
Modified LIFT Versus Standard LIFT for Transsphincteric Anal Fistula
Modified LIFT Via a Lateral Approach Versus Standard LIFT for Transsphincteric Anal Fistula: A Prospective Randomized Study
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This was a prospective, single-center, randomized, parallel-group comparative surgical study conducted at the Department of General Surgery, Kayseri City Training and Research Hospital, Türkiye. The study included adult patients aged 18 to 75 years with magnetic resonance imaging-confirmed transsphincteric anal fistula who met the eligibility criteria and provided written informed consent.
Participants were randomly assigned in a 1:1 ratio to undergo either standard ligation of the intersphincteric fistula tract (LIFT) or modified LIFT via a lateral approach. All patients were evaluated by the same surgical team, and postoperative follow-up was performed at weeks 1, 4, 8, and 12.
The study compared early clinical outcomes between the two procedures, including wound healing time, early recurrence or persistence, postoperative pain, and fecal continence. The study was approved by the Kayseri City Hospital Clinical Research Ethics Committee before patient enrollment.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Kayseri
-
Kayseri, Kayseri, Tyrkiet (Türkiye), 38300
- Kayseri City Training and Research Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Age 18 to 75 years
- Diagnosis of transsphincteric anal fistula confirmed by pelvic magnetic resonance imaging
- Presence of clinical findings consistent with perianal fistula, such as perianal discharge, palpable swelling, or history of perianal abscess drainage
- Ability and willingness to provide written informed consent
- Eligibility for surgical treatment with either standard LIFT or modified LIFT via a lateral approach
Exclusion Criteria:
- Previous definitive surgery for perianal fistula other than abscess drainage
- Perianal Crohn disease
- Horseshoe fistula
- Colorectal cancer
- Malnutrition
- Recurrent anal fistula
- Previous radiotherapy or chemotherapy
- Chronic medication use that could impair wound healing, such as steroids or colchicine
- Refusal or inability to provide written informed consent
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Modified LIFT via a Lateral Approach
Participants assigned to this arm underwent modified LIFT via a lateral approach.
The fistula tract was approached from the external opening, dissected and mobilized toward the internal sphincter level, excised at this level, and the remaining defect and internal opening were closed while preserving sphincter integrity.
|
Modified LIFT via a lateral approach was performed.
The fistula tract was approached from the external opening, dissected and mobilized toward the internal sphincter level, excised at that level, and the remaining defect and internal opening were closed.
|
|
Aktiv komparator: Standard LIFT
Participants assigned to this arm underwent standard ligation of the intersphincteric fistula tract (LIFT).
The intersphincteric plane was approached, and the fistula tract was identified, ligated, and divided according to the standard LIFT technique.
|
Standard ligation of the intersphincteric fistula tract was performed.
The intersphincteric plane was approached, and the fistula tract was identified, ligated, and divided according to the standard LIFT technique.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Wound Healing Time
Tidsramme: Up to 12 weeks after surgery
|
Time from surgery to complete clinical epithelialization of the perianal wound without discharge.
|
Up to 12 weeks after surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Early Recurrence or Persistence of Anal Fistula
Tidsramme: Postoperative weeks 1, 4, 8, and 12
|
Presence of persistent or recurrent fistula-related symptoms or clinical findings during postoperative follow-up.
|
Postoperative weeks 1, 4, 8, and 12
|
|
Postoperative Pain Assessed Using the Visual Analog Scale
Tidsramme: Postoperative weeks 1, 4, 8, and 12
|
Postoperative pain will be assessed using the Visual Analog Scale.
The score ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate worse pain.
|
Postoperative weeks 1, 4, 8, and 12
|
|
Fecal Continence Assessed Using the Wexner Fecal Incontinence Score
Tidsramme: Postoperative weeks 1, 4, 8, and 12
|
Fecal continence will be assessed using the Wexner Fecal Incontinence Score.
The score ranges from 0 to 20, where 0 indicates perfect continence and 20 indicates complete fecal incontinence.
Higher scores indicate worse continence.
|
Postoperative weeks 1, 4, 8, and 12
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Tuğberk Tok, MD, Kayseri City Training and Research Hospital
- Studieleder: Yusuf Sevim, MD, Kayseri City Training and Research Hospital
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- KCTRH-LIFT-944-2023
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Transsfinkterisk anal fistel
-
Cairo UniversityRekrutteringHøj anal fistel | Anal fistelkirurgiEgypten
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeAnal basaloid karcinom | Anal Canal Cloacogenic Carcinom | Anal kanal planocellulært karcinom | Anal margin planocellulært karcinom | Stadie I Anal Cancer AJCC v8 | Stage IIA Anal Cancer AJCC v8Forenede Stater
-
The Cleveland ClinicBard LtdAfsluttet
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetStage III anal cancer AJCC v8 | Anal kanal planocellulært karcinom | Stadie IIB Anal Cancer AJCC v8 | Stadie IIIA anal cancer AJCC v8 | Stadie IIIB anal cancer AJCC v8 | Stadie IIIC anal cancer AJCC v8 | Stadie I Anal Cancer AJCC v8 | Stadie II anal kræft AJCC v8 | Stage IIA Anal Cancer AJCC v8Forenede Stater
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupAktiv, ikke rekrutterendeAnal basaloid karcinom | Anal Canal Cloacogenic Carcinom | Stage III anal cancer AJCC v8 | Anal margin planocellulært karcinom | Stadie IIB Anal Cancer AJCC v8Forenede Stater, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetAnal planocellulært karcinom | Stage III anal cancer AJCC v8 | Stadie IIB Anal Cancer AJCC v8 | Stadie IIIA anal cancer AJCC v8 | Stadie IIIB anal cancer AJCC v8 | Stadie IIIC anal cancer AJCC v8 | Stadie I Anal Cancer AJCC v8 | Stadie II anal kræft AJCC v8 | Stage IIA Anal Cancer AJCC v8 | Trin 0 Anal Cancer...Forenede Stater
-
Hospices Civils de LyonAfsluttet
-
Sun Yat-sen UniversityAfsluttetAnal Canal Cancer | Anal planocellulært karcinom | Anal kræft | Anal Cancer Stadium I | Anal Cancer Stadium II | Anal Cancer Stadium IIIKina
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeAnal basaloid karcinom | Anal Canal Cloacogenic Carcinom | Metastatisk anal planocellulært karcinom | Tilbagevendende anal planocellulært karcinom | Stage III anal cancer AJCC v8 | Stadie IV analkræft AJCC v8 | Uoperabelt anal planocellulært karcinomForenede Stater
-
Cairo UniversityRekruttering